The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of ...

Activist investor won’t push for board seats, but could still agitate from the sidelines if Pfizer’s stock continues to ...

Radiotherapy, China's biotech surge and AI's role in drug discovery are notable topics that emerged from conversations on the ...

Surgery centers are the next focus, President and CEO Martin Bonick told a recent industry conference. But that push is more ...

Pfizer Inc. got a reprieve — at least for now — in its battle with activist investor Starboard Value LP, according to people familiar with the matter.

Voya Financial (NYSE:VOYA – Get Free Report) is expected to post its quarterly earnings results after the market closes on ...

The positive results from the second part of the EMBARK trial contrast with findings from one-year post treatment, which did ...

Last week's ICR Conference in Orlando shed light on how tech and AI are making inroads into improving restaurant experiences and increasing efficiency among quick-service eating establishments.

Jeremy Barnum, Chief Financial Officer of JPMorgan Chase & Co., will present at the UBS Financial Services Forum at the Ritz ...

UNC Health and Duke Health formed a joint venture to build a 500-bed, free-standing children's hospital in the Piedmont, ...

A year after reducing half of its workforce, Allakos will downsize to just 15 employees as it halts the development of AK006.